Survey 34 - Nasal polyposisMCI Registration NumberFULL NAME (As in your Pancard)EmailPhone/MobileCityStateSpecialityBank DetailsAccount Holder NameA/c NumberIFSC CodeUpload Cancelled Cheque (Max Size - 2 MB)Choose File Pancard NumberUpload Pancard Details (Max Size - 2 MB)Choose File Clinical Insights Mapping-“Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP): Insights, Interventions & HCP Perspectives in Real-World Management”1. Average number of CRSwNP patients you see per month: Less than 5 5–10 11–20 More than 202. In your practice, CRSwNP patients are most commonly associated with: (Select multiple)Allergic rhinitisAsthma / AERDRecurrent acute sinusitisAspirin sensitivityNo major comorbidities3. What tools do you most commonly use to diagnose and assess CRSwNP severity? (Select all that apply)Nasal endoscopyCT scan (Lund–Mackay)Symptom severity & patient complaintsSmell assessmentBlood eosinophil/IgE levelsCombination of above4. Which symptom most strongly drives you to initiate or escalate treatment? Nasal obstruction Loss of smell (anosmia/hyposmia) Recurrent infections Facial pain/pressure Poor quality of life/sleep disturbance5. Your usual first-line therapy for newly diagnosed CRSwNP: Intranasal corticosteroids alone Intranasal steroids + saline irrigation Short course oral steroids + intranasal steroids Antihistamines + intranasal steroids Depends on severity6. In your experience, what limits long-term control with intranasal steroids? Poor patient adherence Incorrect spray technique Inadequate symptom relief Frequent relapse after stopping therapy Cost or availability Steroid fear/compliance issues7. How often do you use systemic (oral) corticosteroids in CRSwNP management? Frequently (repeated courses) Occasionally (exacerbations only) Rarely Avoid as much as possible8. What are your main indications for referring or planning surgery (FESS) in CRSwNP? Failure of maximal medical therapy Severe nasal obstruction Recurrent disease despite treatment Asthma worsening due to nasal disease Frequent oral steroid dependence Patient preference9. After surgery, what is the most common challenge you observe? High recurrence of polyps Poor adherence to maintenance therapy Persistent loss of smell Recurrent infections Patient expectations not met10. In patients with recurrent or severe CRSwNP, what is your current approach? Repeated courses of oral steroids Revision surgery Long-term topical therapy optimization Consider biologics (where available) Referral to higher center11. What are the main barriers to using newer/advanced therapies (e.g., biologics) in CRSwNP? Cost / reimbursement issues Limited availability Patient selection uncertainty Long-term safety concerns Lack of real-world experience Patient acceptance12. How do you primarily assess treatment success in CRSwNP? Reduction in polyp size/endoscopic findings Improvement in nasal symptoms Improvement in smell & quality of life Reduction in oral steroid or surgery need Combination of clinical and objective outcomes13. In your opinion, what would MOST improve long-term outcomes in CRSwNP? Better patient education & adherence Early identification of high-risk patients Steroid-sparing long-term therapies Multidisciplinary approach (ENT + Pulmonologist/Allergist) Access to advanced therapies I have read and agree to the Terms and Conditions .Submit Form